# Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit

> **NCT05557474** · — · RECRUITING · sponsor: **Chung Shan Medical University** · enrollment: 236 (estimated)

## Conditions studied

- Lung Cancer
- Surgery
- Recurrence

## Interventions

- **OTHER:** Early-stage lung cancer prognostic kit -- ELISA
- **OTHER:** Early-stage lung cancer prognostic kit -- IHC

## Key facts

- **NCT ID:** NCT05557474
- **Lead sponsor:** Chung Shan Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05557474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05557474, "Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05557474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*